Evaluation of FKB238 and Avastin in Patients With Advanced/Recurrent Non-squamous Non-small Cell Lung Cancer
Clinical trial NCT02810457 · COMPLETED
Trial details
- NCT number
- NCT02810457
- Sponsor
- Centus Biotherapeutics Limited
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-07
- Primary completion
- 2019-01-24
- Enrollment
- 731
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.